<< Lawmakers keep talking with constituents about health overhaul | Children suffering from chronic headache may outgrow the condition >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Telephone counseling and referral service launched for ovarian cancer affected women

Published on September 1, 2009 at 11:41 PM · No Comments

Women with ovarian cancer can now find immediate assistance to better cope with their diagnosis by calling 877-OV-HOPE-1 (877-684-6731), a new, free telephone counseling and referral service launched today by a unique partnership: L'Oreal Paris and its charitable partner, the Ovarian Cancer Research Fund (OCRF), and CancerCare, a national non-profit which provides free counseling and education services to individuals and families affected by cancer.

"Any cancer diagnosis is a frightening and stressful experience that can be difficult to cope with," noted Rosalie Canosa, director of program services for CancerCare. "When the diagnosis is ovarian cancer, too many women have no place to turn for help with the emotional and practical impact of their situation."

Ovarian cancer is the eighth most common cancer among U.S. women. This year, approximately 22,000 women will be diagnosed, and nearly 15,000 will lose their lives to the disease, according to the National Cancer Institute. While five-year survival rates exceed 90 percent in early-stage diagnoses, there is no effective early-stage test for the disease, which often is not diagnosed until it reaches an advanced stage, when it is far more difficult to treat successfully.

"Now, with the L'Oreal Paris OCRF Hope Line, women facing ovarian cancer can have their questions answered and find the resources they require to ensure they receive the best care possible," said Canosa.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading